Open AccessConstruct Validity Supports Use of a Novel, Tablet-Based Neurocognitive Assessment for Adolescents and Young Adults Affected by Perinatal HIV from Vulnerable Communities in the United States
Author(s) -
Reuben N Robbins,
Luke Kluisza,
J Liu,
Anthony F. Santoro,
Jeannette Raymond,
N Ngyuen,
Sarah Espinel,
Eva Laura Siegel,
Curtis Dolezal,
Andrew Wiznia,
Elaine J. Abrams,
Claude A. Mellins
Publication year - 2020
Publication title -
aids and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.994
H-Index - 106
eISSN - 1573-3254
pISSN - 1090-7165
DOI - 10.1007/s10461-020-03099-3
Subject(s) - neurocognitive , construct validity , health psychology , psychology , human immunodeficiency virus (hiv) , working memory , young adult , clinical psychology , gold standard (test) , construct (python library) , developmental psychology , medicine , cognition , psychometrics , public health , psychiatry , family medicine , nursing , computer science , programming language
Construct validity of novel tablet-based neurocognitive tests (in the NeuroScreen app) measuring processing speed, working memory, and executive functioning in adolescents and young adults (AYA) living with perinatally-acquired HIV (PHIV) and perinatal HIV-exposure without infection (PHEU) was examined. Sixty-two AYA (33 PHIV, 29 PHEU) were recruited from an ongoing longitudinal study (CASAH) in New York City. Medium to large and statistically significant correlations were found between NeuroScreen and gold standard, paper-and-pencil tests of processing speed, working memory, and executive functioning. Results provide partial support for NeuroScreen as an alternative to cumbersome paper-and-pencil tests for assessing neurocognition among HIV-affected AYA.